<DOC>
	<DOCNO>NCT01077180</DOCNO>
	<brief_summary>The Rheos Feasibility Trial design assess safety , device performance , protocol parameter CVRx Rheos Baroreflex Therapy patient severe hypertension refractory full drug therapy .</brief_summary>
	<brief_title>Rheos Feasibility Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>1 . Be least 21 year age . 2 . Have assess bilateral carotid bifurcation locate C3C4 . 3 . Have office cuff systolic blood pressure great equal 160 mmHg 24hour ambulatory systolic blood pressure great equal 150 mmHg despite least one month full therapy least three ( 3 ) antihypertensive medication , least one ( 1 ) must diuretic . 4 . Must certify investigator hypertension specialist compliant take full dos medication . 5 . Have sign CVRx approve informed consent participation study . 1 . Have diagnose : Baroreflex failure Cardiac bradyarrhythmias Chronic atrial fibrillation 2 . Had heart transplant 3 . Have carotid atherosclerosis produce 50 % great reduction linear diameter determine ultrasound angiographic evaluation determine within six month enrollment trial . 4 . Have Grade C ulcerative plaque carotid artery determine ultrasound angiographic evaluation . 5 . Have prior surgery radiation either carotid sinus region . 6 . Currently implanted electrical medical device cardiac pacing , defibrillation neurologic stimulation system . 7 . Are pregnant contemplate pregnancy 13month followup period . 8 . Currently undergoing dialysis . 9 . Have hypertension secondary treatable cause . 10 . Have clinically significant cardiac valvular disease . 11 . Are unable unwilling fulfill protocol medication compliance followup requirement . 12 . Are unlikely survive protocol followup period . 13 . Are enrol another concurrent clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>